These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26496190)

  • 1. Use of Chronic Kidney Disease to Enhance Prediction of Cardiovascular Risk in Those at Medium Risk.
    Chia YC; Lim HM; Ching SM
    PLoS One; 2015; 10(10):e0141344. PubMed ID: 26496190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial function and cardiovascular events in chronic kidney disease.
    Hirata Y; Sugiyama S; Yamamoto E; Matsuzawa Y; Akiyama E; Kusaka H; Fujisue K; Kurokawa H; Matsubara J; Sugamura K; Maeda H; Iwashita S; Jinnouchi H; Matsui K; Ogawa H
    Int J Cardiol; 2014 May; 173(3):481-6. PubMed ID: 24703800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should eGFR and albuminuria be added to the Framingham risk score? Chronic kidney disease and cardiovascular disease risk prediction.
    Chang A; Kramer H
    Nephron Clin Pract; 2011; 119(2):c171-7; discussion c177-8. PubMed ID: 21811078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD.
    Spoto B; Mattace-Raso F; Sijbrands E; Leonardis D; Testa A; Pisano A; Pizzini P; Cutrupi S; Parlongo RM; D'Arrigo G; Tripepi G; Mallamaci F; Zoccali C
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):232-40. PubMed ID: 25492254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk prediction in chronic kidney disease patients.
    Cedeño Mora S; Goicoechea M; Torres E; Verdalles Ú; Pérez de José A; Verde E; García de Vinuesa S; Luño J
    Nefrologia; 2017; 37(3):293-300. PubMed ID: 28495396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of 2 risk prediction models in predicting the risk of atherosclerosis in patients with chronic kidney disease.
    Chen S; Li N; Shen Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Sept 28; 46(9):966-973. PubMed ID: 34707006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk stratification of cardiovascular events in patients at all stages of chronic kidney disease using myocardial perfusion SPECT.
    Yoda S; Nakanishi K; Tano A; Kasamaki Y; Kunimoto S; Matsumoto N; Sato Y; Hirayama A
    J Cardiol; 2012 Nov; 60(5):377-82. PubMed ID: 22890072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk is similar in patients with glomerulonephritis compared to other types of chronic kidney disease: a matched cohort study.
    Hutton HL; Levin A; Gill J; Djurdjev O; Tang M; Barbour SJ
    BMC Nephrol; 2017 Mar; 18(1):95. PubMed ID: 28320366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socio-economic disparities in the distribution of cardiovascular risk in chronic kidney disease stage 3.
    Fraser SD; Roderick PJ; McIntyre NJ; Harris S; McIntyre CW; Fluck RJ; Taal MW
    Nephron Clin Pract; 2012; 122(1-2):58-65. PubMed ID: 23548499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk estimated in renal transplant recipients with the Framingham score.
    de Pádua Netto MV; Bonfim TC; Costa EN; de Lima HV; Netto LC
    Transplant Proc; 2012 Oct; 44(8):2337-40. PubMed ID: 23026587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of renal damage with cardiovascular diseases is independent of individual cardiovascular risk profile in hypertension: data from the Italy - Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study.
    Sciarretta S; Valenti V; Tocci G; Pontremoli R; Rosei EA; Ambrosioni E; Costa V; Leonetti G; Pessina AC; Trimarco B; Chin D; Paneni F; Deferrari G; Ferrucci A; Volpe M
    J Hypertens; 2010 Feb; 28(2):251-8. PubMed ID: 19812502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicardial fat accumulation, cardiometabolic profile and cardiovascular events in patients with stages 3-5 chronic kidney disease.
    Cordeiro AC; Amparo FC; Oliveira MA; Amodeo C; Smanio P; Pinto IM; Lindholm B; Stenvinkel P; Carrero JJ
    J Intern Med; 2015 Jul; 278(1):77-87. PubMed ID: 25556720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial.
    Goicoechea M; Garcia de Vinuesa S; Verdalles U; Verde E; Macias N; Santos A; Pérez de Jose A; Cedeño S; Linares T; Luño J
    Am J Kidney Dis; 2015 Apr; 65(4):543-9. PubMed ID: 25595565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of clustering of major cardiovascular risk factors with chronic kidney disease in the adult population.
    Kong X; Ma X; Cui M; Xu D
    Clin Nephrol; 2014 Aug; 82(2):92-7. PubMed ID: 24887299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeat testing is essential when estimating chronic kidney disease prevalence and associated cardiovascular risk.
    Brook MO; Bottomley MJ; Mevada C; Svistunova A; Bielinska AM; James T; Kalachik A; Harden PN
    QJM; 2012 Mar; 105(3):247-55. PubMed ID: 21964723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk prediction in chronic kidney disease: pitfalls and caveats.
    Rigatto C; Sood MM; Tangri N
    Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):612-8. PubMed ID: 23042027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control.
    Parikh NI; Hwang SJ; Larson MG; Meigs JB; Levy D; Fox CS
    Arch Intern Med; 2006 Sep; 166(17):1884-91. PubMed ID: 17000946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney function, electrocardiographic findings, and cardiovascular events among older adults.
    Kestenbaum B; Rudser KD; Shlipak MG; Fried LF; Newman AB; Katz R; Sarnak MJ; Seliger S; Stehman-Breen C; Prineas R; Siscovick DS
    Clin J Am Soc Nephrol; 2007 May; 2(3):501-8. PubMed ID: 17699457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.